Alivus Life Sciences schedules November investor and analyst meetings

Alivus Life Sciences Limited has announced upcoming meetings with investors and analysts, in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The company will engage with Quantum AMC on November 19, 2025, in an in-person, one-on-one meeting in Mumbai. A second meeting is scheduled for November 24, 2025, with Axis Securities PMS, which will be a virtual one-on-one session.

The company noted that the schedule and mode of these meetings are subject to change due to exigencies on the part of the investor, analyst, or company. These interactions are part of Alivus Life Sciences' ongoing commitment to transparency and communication with the financial community.

The disclosure was signed by rudalf corriea, company secretary & compliance officer, on November 14, 2025.